Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121983) titled 'A Study on the Effects of Stellate Ganglion Block Combined with Esketamine on Postpartum Depression after Cesarean Section' on April 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ganzhou People's Hospital
Condition:
postnatal depression
Intervention:
Control group1:PCIA (Esketamine 0.2mg/kg + Sufentanil 1.5µg/kg)
Control group2:Ultrasound-guided ropivacaine stellate ganglion block combined with PCIA (sufentanil 1.5 µg/kg)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-05-01
Target Sample Size: Control group1:42;Control group2:42;Ex...